Cargando…
Sphingolipid Pathway as a Source of Vulnerability in IDH1(mut) Glioma
SIMPLE SUMMARY: The presence of the IDH mutation in glioma raises the possibility that these CNS malignancies could be targeted with metabolic-based therapeutics, however, the exploration of the role that regulatory lipids, such as sphingolipids serve within the IDH1(mut) gliomas remains limited. Ou...
Autores principales: | Dowdy, Tyrone, Zhang, Lumin, Celiku, Orieta, Movva, Sriya, Lita, Adrian, Ruiz-Rodado, Victor, Gilbert, Mark R., Larion, Mioara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601159/ https://www.ncbi.nlm.nih.gov/pubmed/33050528 http://dx.doi.org/10.3390/cancers12102910 |
Ejemplares similares
-
DDRE-20. TARGETING SPHINGOLIPID PATHWAY REVEALS VULNERABILITY IN IDH1(MUT) GLIOMA
por: Dowdy, Tyrone, et al.
Publicado: (2021) -
BIMG-10. IDH1 MUTATIONS INDUCE ORGANELLE DEFECTS VIA DYSREGULATED PHOSPHOLIPIDS
por: Yamasaki, Tomohiro, et al.
Publicado: (2021) -
Targeting the Sphingolipid Rheostat in Gliomas
por: Zaibaq, Faris, et al.
Publicado: (2022) -
Metabolic Landscape of a Genetically Engineered Mouse Model of IDH1 Mutant Glioma
por: Ruiz-Rodado, Victor, et al.
Publicado: (2020) -
DDRE-01. METABOLIC PLASTICITY AND HETEROGENEITY IN IDH1MUT CELL LINES PRODUCES RESISTANCE TO GLUTAMINASE INHIBITION BY CB839
por: Larion, Mioara, et al.
Publicado: (2021)